APA (7th ed.) Citation

Ferrando, R., Echave, M., Espinoza Cámac, N., Maratia, S., & Casado, M. (2020). PMS21 Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain. Value in Health, 23, S596. https://doi.org/10.1016/j.jval.2020.08.1152

Chicago Style (17th ed.) Citation

Ferrando, R., M. Echave, N. Espinoza Cámac, S. Maratia, and M.Á Casado. "PMS21 Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain." Value in Health 23 (2020): S596. https://doi.org/10.1016/j.jval.2020.08.1152.

MLA (9th ed.) Citation

Ferrando, R., et al. "PMS21 Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain." Value in Health, vol. 23, 2020, p. S596, https://doi.org/10.1016/j.jval.2020.08.1152.